Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.

Source:http://linkedlifedata.com/resource/pubmed/id/12956739

Download in:

View as

General Info

PMID
12956739